Clinical trial
Combination Chemotherapy in Treating Patients With Previously Untreated Advanced…
NCT00041210 · Mount Vernon Cancer Centre at Mount Vernon Hospital, Other · Unknown status
Key facts
| NCT number | NCT00041210 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma |
| Official title | Protocol for a Randomized Phase III Study of the Stanford V Regimen, Compared With ABVD for the Treatment of Advanced Hodgkin's Disease |
| Lead sponsor | Mount Vernon Cancer Centre at Mount Vernon Hospital, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | bleomycin sulfate, ABVD regimen, Stanford V regimen, dacarbazine, doxorubicin hydrochloride, etoposide, mechlorethamine hydrochloride, prednisone, vinblastine sulfate, vincristine sulfate and 1 more |
| Enrollment | 850 |
| Start date | Oct 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: